A. Clayton Perfall of Colfax in second quartile of Large MCap Director Scorecard for past year 26 February 2021

NEWS BITES - PEOPLE IN BUSINESS

A. Clayton Perfall's performance as Director of Colfax is ranked in the second quartile of BuySellSignals Large MCap performers for the past year; a percentile ranking of 50.3. The shares were up 22.6% in USD terms for the year ended February 24, 2021.

IN TODAY'S REPORT:

SECTION 1 BIOGRAPHY: A. CLAYTON PERFALL

SECTION 2 COLFAX: CORPORATE PROFILE

SECTION 3 RECENT NEWS ON DIRECTORS

SECTION 4 COLFAX: INDEPENDENT RATINGS

SECTION 5 COLFAX: PRICE PERFORMANCE SCORECARD

SECTION 6 FINANCIALS AND GROWTH PERFORMANCE SCORECARD

SECTION 7 COLFAX: GLOBAL RANK

SECTION 1 BIOGRAPHY: A. CLAYTON PERFALL, DIRECTOR

A. Clayton Perfall has served as a director of the Company since September 21, 2010. He is currently an Operating Executive of Tailwind Capital, a private equity fund manager focused on growing middle market companies in the healthcare and business & communications services sectors. He previously served as the Chairman and Chief Executive Officer of Archway Marketing Services, Inc., a provider of marketing logistics and fulfillment services, from 2008 through 2013. From 2001 until 2008 Mr. Perfall served as the Chief Executive Officer and as a member of the Board of Directors of AHL Services, Inc. Mr. Perfall also served as the Chief Executive Officer of Union Street Acquisition Corp. from 2006 until 2008. He served as the Chief Financial Officer of Snyder Communications, Inc. from 1996 until 2000 and was previously a partner with a large international accounting firm. Mr. Perfall currently serves on the Boards of Directors of Tailwind Premier Holdings, LLC, Distinct Holdings Group, LLC and Comstock Holding Companies, Inc., and previously served on the Boards of Directors of Archway Marketing Services, Inc. from 2008 until 2013, RT Acquisition Corp. from 2012 until 2015 and inVentiv Health, Inc. from 1999 to 2010. He is currently the audit committee chairman for Comstock Homebuilding Companies, Inc. and served as the chair of the audit committee during his time on the board of inVentiv Health. Mr. Perfall's significant financial expertise and experience as an audit committee chairman and public company Chief Financial Officer, combined with his substantial executive leadership background, are assets to both our Board and our Audit Committee.

SECTION 2 COLFAX: CORPORATE PROFILE

2.1 Colfax Activities

Colfax Corporation's pump and other fluid-handling product brands are known for providing the best solutions for its customers. It is the NYSE's 16th largest Industrial machinery company by market cap.

2.2 Other directors of Colfax

Christopher Hix, Chief Financial Officer

Sharon Wienbar, Director

Rhonda L. Jordan, Director

Didier Teirlinck, Director

Rajiv Vinnakota, Director

Patrick W. Allender, Director

Thomas S. Gayner, Director

A. Clayton Perfall, Director

Matthew L. Trerotola, Director

Philip Okala, Director

Daniel A. Pryor, Executive Vice President

Shyam Kambeyanda, Executive Vice President

Patricia Lang, Senior Vice President

Bradley J. Tandy, Senior Vice President

Jason MacLean, Senior Vice President

2.3 CFX Stock Dashboard [traded in US Dollars, USD]

Feb 24 close$46.19
EPS Growth % (Q3 2020 vs Q3 2019)25.0
Ave Daily Volume1,901,702 shares
52-Week Range (In USD)12.23 - 46.45
SectorIndustrial Machinery
Market Cap$5.5 billion
EPS (FY2019)($4)
Shares Outstanding118,390,000
% Held by 15 Insiders1.1%

SECTION 3 RECENT NEWS ON DIRECTORS

24 February 2021

Colfax director Matthew L. Trerotola awarded shares

Colfax (NYSE:CFX) Director Matthew L. Trerotola, was awarded 38,789 shares worth $1.7 million on February 22.

24 February 2021

Colfax director Matthew L. Trerotola awarded Employee Stock Options

Colfax (NYSE:CFX) Director Matthew L. Trerotola, has been awarded Employee Stock Options on 95,502 shares at an exercise price of $44.91. The transaction date was February 22. The shares last traded at $46.19.

24 February 2021

Colfax executive vice president Shyam Kambeyanda awarded shares

Colfax (NYSE:CFX) Executive Vice President Shyam Kambeyanda, was awarded 9,384 shares worth $421,435 on February 22.

24 February 2021

Colfax executive vice president Daniel A. Pryor awarded shares

Colfax (NYSE:CFX) Executive Vice President Daniel A. Pryor, was awarded 11,574 shares worth $519,788 on February 22.

24 February 2021

Colfax executive vice president Daniel A. Pryor awarded Employee Stock Options

Colfax (NYSE:CFX) Executive Vice President Daniel A. Pryor, has been awarded Employee Stock Options on 28,497 shares at an exercise price of $44.91. The transaction date was February 22. The shares last traded at $46.19.

24 February 2021

Colfax CFO Christopher Hix awarded shares

Colfax (NYSE:CFX) Chief Financial Officer Christopher Hix, was awarded 12,513 shares worth $561,959 on February 22.

24 February 2021

Colfax senior vice president Bradley J. Tandy awarded shares

Colfax (NYSE:CFX) General Counsel and Senior Vice President Bradley J. Tandy, was awarded 5,005 shares worth $224,775 on February 22.

24 February 2021

Colfax senior vice president Patricia Lang awarded shares

Colfax (NYSE:CFX) Chief Human Resources Officer and Senior Vice President Patricia Lang, was awarded 5,005 shares worth $224,775 on February 22.

24 February 2021

Colfax CFO Christopher Hix awarded Employee Stock Options

Colfax (NYSE:CFX) Chief Financial Officer Christopher Hix, has been awarded Employee Stock Options on 30,807 shares at an exercise price of $44.91. The transaction date was February 22. The shares last traded at $46.19.

24 February 2021

Colfax executive vice president Shyam Kambeyanda awarded Employee Stock Options

Colfax (NYSE:CFX) Executive Vice President Shyam Kambeyanda, has been awarded Employee Stock Options on 23,105 shares at an exercise price of $44.91. The transaction date was February 22. The shares last traded at $46.19.

24 February 2021

Colfax senior vice president Bradley J. Tandy awarded Employee Stock Options

Colfax (NYSE:CFX) General Counsel and Senior Vice President Bradley J. Tandy, has been awarded Employee Stock Options on 12,323 shares at an exercise price of $44.91. The transaction date was February 22. The shares last traded at $46.19.

24 February 2021

Colfax senior vice president Patricia Lang awarded Employee Stock Options

Colfax (NYSE:CFX) Chief Human Resources Officer and Senior Vice President Patricia Lang, has been awarded Employee Stock Options on 12,323 shares at an exercise price of $44.91. The transaction date was February 22. The shares last traded at $46.19.

SECTION 4 COLFAX: INDEPENDENT RATINGS

+ Industryweek 1000:

Colfax Corporation is a new entrant in the Industry Week list of the world's largest 1000 manufacturers by Revenues in 2016, ranked 853.

SECTION 5 COLFAX: PRICE PERFORMANCE SCORECARD (NYSE: (USNYSE:CFX)):

5.1 Created Market Value [CMV] past 11 yrs of $4.1 billion

Market Capitalization has increased by $4.5 billion from $950.6 million to $5.5 billion in the last 11 years. This increase comprises cumulative retained earnings (RETE) of $366.3 million and Created Market Value of $4.1 billion. The Created Market Value multiple, defined by the change in MCap for every $1 of retained earnings is exemplary at $12.29.

YearsCMV Value (Billion)RETE (Million)Multiple
2$2.1 $207.4 $11.20
5$2.2 $90 $25.30
10$2.8 $555.8 $6.04

5.2 Total Shareholder Returns [TSR] (Past 5 years)

Colfax (NYSE:CFX) is ranked in the second quartile of BuySellSignals performers for the past five years; a percentile ranking of 73. In the last 5 years the average annualized return to shareholders was 11.7%. The 5-year average return is ranked 12,935 out of 55,655 public companies traded globally. The present value of US$1,000 (PV1000) invested 5 years ago is now worth $1,826; a capital gain of $826.

5.3 Annualised Period-based Total Shareholder Returns [TSR %]: The Best Periods with TSR > 7.8%

TSR %1 yr3 yrs5 yrs10 yrs
CFX.NYSE22.611.612.87.9

5.4 Bullish Signals: Stocks Hitting Consecutive Highs

Colfax (CFX:$46.19) hits year-high 6th time in three months

Colfax Corporation (NYSE:CFX), the NYSE's 16th largest Industrial machinery company by market cap, hit a 52-week high of $46.45 during the day. In the past month the stock has hit a new 52-week high four times and in the last three months six times, pointing to an uptrend.

Colfax's stock price has lifted $1.30 (2.9%) from its previous trading session to close at $46.19. Compared with the S&P 500 Index which rose 44.1 points (1.1%) in the day, the relative price increase was 1.8%.

There were 1,225,700 shares worth $56.6 million traded today. The volume was 0.6 times the average daily trading volume of 1.9 million shares.

5.5 MCap History:

MCap: 5-Year Increase of $2 billion

In the past 5 years Market Capitalization has increased by $2.3 billion (75%) from $3.1 billion to $5.5 billion. Based on a dynamic start date of 5 years ago, there have been declines in MCap in 2 out of 5 years.

PriceMCap ($ M)
Last$46.195,468.4
1 Year ago$37.674,435.9
2 Years ago$26.843,145.6
3 Years ago$33.114,083.4
4 Years ago$38.474,726.4
5 Years ago$25.293,128

5.6 Moving Annual Return of 22.6% in the past year:

Moving Annual Return was 22.6% in the past year. Based on a dynamic start date of 5 years ago, the real rate of return has averaged 16.5%. The Moving Annual Return has been positive in 3 of the last 5 years.

CFXClose ($)Annual Return %
Feb 2446.1922.6
1 Yr ago37.6740.4
2 Yrs ago26.84(18.9)
3 Yrs ago33.11(13.9)
4 Yrs ago38.4752.1

Close 5 years ago $25.29

5.7 Present Value of $1000 invested in the past

The present value of $1000 invested a year ago is $1,226

PV$10001-week1-month1-year
CFX.NYSE1,2061,1521,226
S&P 500 Index9991,0261,217

5.8 Price Change % (1 Mo, 3 Mo, 1 Yr)

1-Year price change of 22.6% for Colfax outperformed the change of 17.6% in the S&P 500 Index for a relative price change of 5.0%.

Price Change %1-Month3-Month1-Year
CFX15.222.822.6
Industrial machinery sector4.77.920.1
S&P 500 Index2.28.217.6

SECTION 6 COLFAX: FINANCIALS AND GROWTH PERFORMANCE SCORECARD (NYSE: (USNYSE:CFX)):

6.1 Annual Financials Ranking

Out of 2,588 stocks in the NYSE Market, Colfax Corporation is ranked 547th by Revenue, 1901st by Net Profit, 1059th by EBITDA Margin and 651st by Debt to Equity.

NYSE AvgCFXRank
Revenue $7.8B3.3B547
Debt to Equity (The lower the better)0.800.70651
EBITDA Margin (%)10.701.501059
Net Profit $494.6M-527.6M1901

6.2 Revenue and Net Profit

In the last 10 years Compound Annual Growth Rate (CAGR) averaged 20.3% for Total Revenue and -0.9% for EBITDA.

DescriptionAnnual ($US M)10-year Avg ($US M)10-year CAGR %
Total Revenue3,327.52,995.420.3
EBITDA50.5213.8-0.9
Operating Profit50.5162.12.5

6.3 Performance (All figures in %)

Net Profit Margin 10-year average is 3.1% and Return on Equity 10-year average is 4.1%.

DescriptionAnnual10-year Avg
EBITDA Margin1.56.9
Operating Profit Margin1.55.1
Net Profit Margin0.63.1
Return on Equity0.54.1
Return on Assets0.31.7
Return on Capital Employed0.83.6

SECTION 7 COLFAX: GLOBAL RANK (NYSE: (USNYSE:CFX)):

7.1 Global Rank

Global Rank [out of 47,723 stocks]

DescriptionValueRankQuartile
MCap (US$)3.9B3,285Top
Total Assets (US$)7.4B3,439Top
Revenue (US$)3.3B3,127Top
Net Profit (US$)(527.6M)42,997Bottom
Return on Equity %0.527,179Third
Net Profit Margin %0.626,157Third
PV$1000 (1Year) US$1,16814,352Second
US$ Change (1Year) %16.813,413Second
Rel Strength 6 Mo (US$)5123,355Second

7.2 Rank in the top 18% by Price Performance in the NYSE market

DescriptionValueRank
1-week Price Change %20.6In Top 2%
Price/MAP501.18In Top 13%
1-month Price Change %15.2In Top 18%

Colfax Corporation

ISIN: US1940141062

PermID: 4296037542

RIC: CFX.N

CIK: 1420800

CUSIP: 194014106

Source: www.BuySellSignals.com